Company Filing History:
4 out of 1,745 
3 out of 5,094 
3 out of 321 
Years Active: 2020-2025
Title: The Innovative Contributions of Sebastien Dumas
Introduction
Sebastien Dumas is a notable inventor based in Le Plessis-Robinson, France. He has made significant contributions to the field of medical research, particularly in the development of compounds that act as peripheral NMDA receptor antagonists. With a total of 4 patents to his name, Dumas has established himself as a key figure in his area of expertise.
Latest Patents
Dumas's latest patents include innovative compounds designed for use as peripheral NMDA receptor antagonists. These compounds are described in detail in his patent titled "Dizocilpine derivatives as peripheral NMDA receptor antagonists." This invention relates to specific compounds of formula (I) that have potential therapeutic applications.
Career Highlights
Throughout his career, Sebastien Dumas has worked with prestigious organizations such as the Institut National de la Santé et de la Recherche Médicale and the Centre National de la Recherche Scientifique. His work in these institutions has allowed him to contribute to groundbreaking research and development in the medical field.
Collaborations
Dumas has collaborated with esteemed colleagues, including Sylvia Cohen-Kaminsky and Gilles Bru-Mercier. These partnerships have further enhanced his research efforts and have led to advancements in the understanding of NMDA receptor antagonists.
Conclusion
Sebastien Dumas's innovative work and patents have made a significant impact in the field of medical research. His contributions continue to pave the way for future advancements in therapeutic applications.